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Summary. Introduction. Multilamellar bodies (MLBs)
are concentric cytoplasmic membranes which form
through an autophagy-dependent mechanism. In the
cornea, the presence of MLBs is associated with
Schnyder corneal dystrophy (SCD). Ex vivo 3D
modelling of the corneal stroma and SCD can help study
pathogenesis and resolution of the disorder. Methods.
Corneal stroma explants were isolated from cadavers
and cultivated long-term for more than 3 months to
achieve spontaneous 3D outgrowth of corneal stroma-
derived mesenchymal stem-like cells (CSMSCs). The
3D tissues were then examined by transmission electron
microscopy (TEM) for presence of MLBs, and by
immunofluorescent labelling against markers for
autophagy (p62, LC3). Autophagy was induced by
classical serum starvation or rapamycin (RAP) treatment
(50nM), and inhibited by the autophagy inhibitor 3-
methyladenine (3-MA, 10 mM) for 24 hours. Results.
CSMSCs can form spontaneously 3D outgrowths over a
3-4 weeks period, depositing their own extracellular
matrix containing collagen I. TEM confirmed the
presence of MLBs in the long-term (>3 months) 3D
cultures, which became more abundant under starvation
and RAP treatment, and decreased in number under
autophagy inhibition with 3-MA. The presence of
autophagy and its disappearance could be confirmed by
an inversely related increase and decrease in the
expression of LC3 and p62, respectively. Conclusions.
MLB formation in long-standing CSMSC cultures could
serve as a potential ex vivo model for studying corneal
stroma diseases, including SCD. Inhibition of autophagy
can decrease the formation of MLBs, which may lead to
a novel treatment of the disease in the future.
Key words: Corneal stroma-derived mesenchymal stem-
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Introduction
The cornea is the outermost layer of the eye, which
serves as a protective barrier to infectious agents and
provides two-thirds of its refractive power. It consists of
5 layers (from anterior to posterior): corneal epithelium,
Bowman’s layer, stroma, Descemet’s membrane and
corneal endothelium (Meek and Knupp, 2015). The
epithelium is the outermost layer which undergoes heavy
cell turnover (supported by the epithelial basement
membrane); the endothelium is the innermost layer built
from a monolayer of cells responsible for maintaining
adequate hydration of the cornea (supported by the
Descemet’s membrane). The stroma represents 90% of
corneal thickness. Under normal conditions, the stroma
is transparent, however, when it comes in contact with
liquids, it becomes edematous and hazy. The stromal
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structure consists of collagen fibrills running parallel to
the ocular surface - mainly collagen I and collagen V,
which are connected or fastened together by
proteoglycans. The specific arrangement of the lamellae
contributes to the transparency of the cornea. 
Between the lamellae are scattered flattened
keratocytes/stromal cells, which are altered fibroblasts of
mesenchymal origin, with long, thin cytoplasmic
processes, creating a communicating 3D network. The
main function of these cells in the normal stroma is to
maintain its structure by producing new ECM
components and secreting enzymes to degrade the old
ECM (Michelacci, 2003). They also have an important
role in wound healing and in keeping the cornea
transparent.
Mesenchymal-derived, adult corneal stroma stem
cells (CSMSCs) residing in the stroma may take part in
the maintenance of the mesenchyme-derived parts of the
cornea, in immune regulation of the surrounding
microenvironment and in wound healing (Takacs et al.,
2009; Vereb et al., 2016). They have the potential to
differentiate into several different cell types, including
keratocytes, chondrocytes, but also neural cells (Du et
al., 2005).
Schnyder corneal dystrophy (SCD) is a rare
hereditary disease characterized by bilateral abnormal
deposition of intracellular and extracellular esterified
and unesterified phospholipids and cholesterol in the
stroma that causes subepithelial opacification posterior
to Bowman’s layer (Weller and Rodger, 1980). Cases
can vary in clinical severity, but the loss of corneal
transparency is progressive. To date, the only treatment
option for SCD has been surgical, involving procedures
such as phototherapeutic keratectomy (PTK), penetrating
keratoplasty or deep anterior lamellar keratoplasty
(Weiss, 2009; Woreta et al., 2015). SCD is often
associated with hyperlipoproteinemia, but not all the
patients have elevated lipoprotein levels in the serum.
Transmission emission microscopy (TEM) shows multi
lamellar bodies (MLBs) in the stroma, especially in the
superficial layers. MLBs are round shaped cytoplasmic
structures surrounded by membrane, containing multiple
concentric electron dense lamellae rich in lipoprotein.
Their diameter ranges from 100-2400 µm, and they are
normally present in the lung in type II pneumocytes,
where they take part in the storage and secretion of
surfactant. They can also appear in different cell types
under pathological conditions, most often in lysosomal
storage diseases, including gangliosidosis, Tay-Sachs,
Fabry and Niemann-Pick (NP). The formation of MLBs
is autophagy-dependent (Hariri et al., 2000). Autophagy
is a controlled degradation of sequestered cytoplasmic
components by lysosomal hydrolytic enzymes. It is
necessary to maintain cellular homeostasis under normal
conditions and in response to stress. Increased autophagy
serves a cell protective role. The lysosomal nature of
autophagic vacuoles (AVs) and MLBs indicate a similar
pathway in their formation. The development of MLBs
in long-term CSMSC cultures indicates that the cells
undergo an intense catabolic degradation, while building
and maintaining a 3D structure. To examine whether this
could be an autophagy related mechanism, the cells in
the 3D corneal stroma outgrowth were treated by 3-MA,
which suppresses autophagy by blocking the synthesis of
autophagosomes at the early stages of autophagy.
The present study establishes a spontaneously
formed 3D model of human corneal stroma ex vivo in
which long-term cultivation is used to induce MLBs in
the CSMSCs, thus serving as a model for studying SCD.
The effect autophagy has upon MLB formation and
dissappearance is further studied by using autophagy-
inducing agents (rapamycin (RAP) and starvation), as
well as autophagy-inhibiting agent 3-MA. The findings
can further serve the purpose of determining drug targets
against SCD.
Materials and methods
Corneal stroma harvesting
All tissue collection complied with the Guidelines of
the Helsinki Declaration and was approved by the
Regional Ethical Committee at the University of
Debrecen, Hungary (DEOEC RKEB/IKEB 3094/2010
and 14415/2013/EKU-183/2013). Hungary follows the
EU Member States' Directive 2004/23/EC on presumed
consent practice for tissue collection. Corneas were
obtained from human cadavers within 24 hours of
biological death. The bulbus and the cornea were
prepared as previously described by our group (Szabo et
al., 2015). Briefly, the bulbi were disinfected by 5%
povidon iodide (Betadine, Egis, Budapest, Hungary) and
after removing the conjunctiva, a corneal button was cut
out. The epithelium with the Bowman’s membrane and
endothelium with the Descemet’s membrane were
removed by scraping. Small, approximately 6-7 mm
diameter cubes were cut out from the central cornea.
Isolation and culturing of CSMSC’s was performed
using three different donor eyes. Average age of the
cultures was 239±130 days (n=3) and average ages of
donors was 60±11.5 years.
Cell culturing and treatments
The central corneal grafts were seeded into 24-well
cell culture plates, cultivated at 37°C, 5% CO2, in low
glucose DMEM (Sigma-Aldrich, St. Louis, MO, USA)
supplemented with 10% fetal calf serum (FCS, Sigma-
Aldrich) and 1% Antibiotic/Antimycotic Solution (PAA,
Pasching, Austria). The cells were expanded in 1 mL of
medium changed on alternating days and maintained
without passaging.
To induce autophagy 50 nM RAP (Sigma-Aldrich)
treatment and serum starvation (serum-free media) was
used respectively for 24 hours. To inhibit autophagy the
cultures were treated with 10 mM 3-MA (Sigma-
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Aldrich), an inhibitor of autophagy, for 24 hours.
Immunofluorescent staining 
Long-standing cultures of CSMSCs were collected
and fixed in 4% paraformaldehyde after peeling off the
cell culture plates using surgical forceps. The fixed 3D
structures were dehydrated in ascending alcohol series
and embedded in paraffin; 3-4 µm thick tissue sections
were prepared using a rotary microtome, then mounted
onto histological slides. After heat-induced antigen
retrieval and blocking, immunofluorescent labelling was
performed. The samples were stained for autophagy
markers: microtubule-associated protein 1 light chain 3
(LC3), p62 protein also called sequestosome 1
(SQSTM1) and extracellular matrix proteins: type I
collagen, type IV collagen, type V collagen. Nuclear
staining was performed using 4',6-diamidino-2-
phenylindole (DAPI) staining. (Table 1 summarizes the
primary and secondary antibodies used for
immunohistochemistry). Fluorescent images were taken
by a ZEISS Axio Observer. Z1 microscope (ZEISS,
Oberkochen, Germany) and an EVOS FL microscope
(Advanced Microscopy Group, Bothell, WA). For image
handling ImageJ software version 1.50 (National
Institutes of Health, Bethesda, MD) was used.
Transmission electronic microscopy
TEM was performed to analyze the ultrastructure of
the 3D CSMSC cultures. After peeling the membrane,
the tissue was fixed in 2.5% glutaraldehyde and 4%
paraformaldehyde with 0.2 M cacodylate buffer for 24
hours. The samples were then rinsed with PBS three
times for 5 minutes each and kept at 4°C. Before Epon
(Electron Microscopy Sciences, Hatfield, PA, USA)
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Fig. 1. Corneal stromal cell outgrowth from explants (*) cultivated ex vivo. Representative images of long-term cultivated cells are shown; 3D layering of
the cells becomes noticable within 3-4 weeks (Day 25 in the images shown). Scale bars: 1000 µm.
embedding the samples were post-fixed in 1% osmium
tetroxide, dehydrated in ascending alcohol series and
briefly immersed in propylenoxide. A Leica Ultracut
Ultramicrotome was used to cut ultra-thin (60-70 nm)
sections which were stained with uranyl acetate and lead
cytrate. The images were taken by a Tecnai 12
transmission electron microscope (Phillips, Amsterdam,
the Netherlands).
Results
Phase contrast images of ex vivo cultivated corneal
stroma grafts showed cell outgrowth from the explant
assuming fibrosblastic morphology within 2 weeks of
cultivation, and continuous monolayer formation during
the weeks 2-3. Upon reaching confluence, the cultures
underwent stratification and formed a 3D structure after
4-5 weeks (Fig. 1).
Immunofluorescent staining of long-term 3D stroma
showed de novo ECM deposition abundant in
multilamellar collagen type I, similar to the tissue of the
native corneal stroma (Fig. 2). In contrast, type IV and V
collagen did not show positivity in the samples (data not
shown).
TEM results show heavy MLB formation, with AVs
being seen in the untreated long-term cultivated corneal
stroma. The effect of RAP treatment and serum
starvation enhanced the expression of MLBs and AVs,
while the 3-MA treatment attenuated it. The
mitochondria seem to be intact under 3-MA treatment
also (Fig. 3).
Similarly, immunohistochemical analysis of typical
autophagy markers LC3 and p62 showed that before
treatment, the 3D corneal stroma tissues contained
positive AVs. Further induction of autophagy by RAP
treatment and serum starvation enhanced the amount of
AVs, while treatment by 3-MA resulted in attenuated
LC3 and p62 expression, and therefore presence of
decreased number of AVs (Fig. 4).
Discussion
The corneal stroma is a specially organized tissue
that serves as a clear, refractive medium. Anything
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Fig. 2. De novo ECM deposition of corneal stroma cells after long–term cultivation. Immunofluorescent staining for collagen I (left, antibody dilution:
1:200, secondary antibody: anti-rabbit, wavelenght: 488 nm) and phase contract image (right) are shown accordingly. Left, x 63; right, x 40.
Table 1. Summary of antibodies used for immunohistochemistry.
Antibody Catalog No. Company Clonality Antigen Dilution Secondary antibody
species dilution
LC3 NB100-2220 Novus Biologicals Rabbit polyclonal MAP1LC3B 1:200 Goat 1:1000
p62 (SQSTM1 (D-3)) Sc-28359 Santa Cruz Mouse monoclonal amino acids 151-440 of SQSTM1 of human origin 1:200 Donkey 1:1000
Collagen I. Ab34710 Abcam Rabbit polyclonal Human collagen I. AA 1-1464 1:200 Donkey 1:1000
Collagen IV #MS-747-S Thermo Scientific Mouse monoclonal Human glomeruli 1:50 Donkey 1:1000
Collagen V Ab7046 Abcam Rabbit polyclonal Full length native protein (purified) 1:500 Donkey 1:1000
corresponding to collagen V. AA 1-1745
disturbing its anatomy is prone to causing reduced
transparency and therefore, impaired vision. The
transparency of the cornea is a consequence of the
detailed ultrastructure of the tissue and depends upon the
organization of type I collagen fibrils which, in the
cornea, are narrower than in many other connective
tissues. This arrangement is sustained by the association
of type I collagen with other ECM molecules such as
type V collagen, fibril-associated collagens with
interrupted triple helices (FACITs) and small leucine-
rich proteoglycans (SLRPs). Beside these, other cellular
components such as the crystallins are also important for
3D stromal corneal dystrophy model
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Fig. 3. TEM of 3D long-term cultures of human corneal stroma and presence of MLBs (arrows) and autophagic vacuoles (*). Scale bars: 1 µm.
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Fig. 4. Immunohistochemical analysis of the 3D corneal stroma tissue for presence of autophagy. Scale bars: 100 µm.
Fig. 5. Proposed mechanism of
Schnyder corneal dystrophy formation
and cleareance of MLBs – potential
implication for drug development.
maintaining corneal transparency, as they confer
transparency to the stromal resident cells – the
keratocytes. Disruption of the corneal stroma type I
collagen organization can lead to corneal transparency
complications such as corneal scarring (Meek and
Fullwood, 2001; Meek and Boote, 2004; Massoudi et al.,
2015; Meek and Knupp, 2015). 
It has been known that cultivation of keratocytes in
serum-containing media generates differentiation into
fibroblasts and partly myofibroblasts (Jester et al., 1996).
Corneal fibroblasts can create a self-assembled 3D
structured tissue consisting of collagen type I (in serum
and ascorbic acid supplemented media) that shows close
histological resemblance to human native cornea stroma
(Proulx et al., 2010). These 3D human fibroblast cultures
grown over long-term on a disorganized collagen
substrate have been found to have proteoglycan
deposition and sulfation throughout the produced
multilayered structure (Ren et al., 2008). TEM images of
such cultures after 8 weeks reported no intracellular
changes or presence of MLBs or any other storage or
clearance pathways’ activation.
Recently, CSMSCs isolated from the cornea limbal
stroma and cultivated in selective stem cell media have
been shown to be able to secrete a well-organized ECM
rich in collagen type I, V and VI, which had greater
resemblance to native stroma tissue than keratocyte-
derived corneal fibroblasts expanded in serum
containing media (Wu et al., 2014). Similarly, we
recently characterized cultured CSMSCs isolated from
the central part of the corneal stroma and showed their
surface marker profile regarding mesenchymal- and
stemness related markers (CD73, CD90, CD105,
CD140b), and lack of hematopoietic markers. The
keratocyte marker CD34 appeared to be negative for
over 10 passages in these cells (Vereb et al., 2016).
An intact and well tangible 3D collagen structure
synthesized by the central corneal stroma-derived
CSMSCs could be maintained over long periods of time
with intracellular changes becoming apparent in the
morphology of CSMSC, which is similar to that seen in
SCD, as large amounts of MLBs accumulate in the cells’
cytoplasm. Likely, the long-term cultures undergo
spontaneous intracellular changes resemblant of MLBs
and that of SCD - a rare autosomal dominant corneal
dystrophy characterized by progressive, abnormal
cholesterol and phospholipid depositions in the cornea.
The diagnosis of SCD is based on observation of crystals
and/or stromal haze, in older patients accompanied by
arcus lipoides. The condition is slowly progressive and
leads to severe reduction of visual acuity in most cases
aged 50 and more. Gradual loss of corneal sensation may
also be present. About 50% of the cases show corneal
crystals, while in the acrystalline form of the dystrophy
these deposits are missing, which can cause difficulties
and delay in the diagnosis (Weiss, 2009). 
Genetic studies show that SCD is caused by
mutations in the UBIAD1 gene located on chromosome
1p36. This gene encodes a protein linked to lipid
metabolism (Orr et al., 2007; Weiss et al., 2007). The
structure of MLBs suggests a local lipid metabolic
disturbance in the pathogenesis of SCD. To date, no
treatment modality is available for stopping or slowing
down SCD progression, nor is there a way to rid the cells
off the MLBs.
MLBs are actually lysosomal organelles expressed
under various physiological and pathological conditions,
which contain multiple concentric membrane layers that
are found in various cell types, where their main
function is storage and secretion of lipids. The role of
autophagy is crucial in MLB biogenesis under normal
cellular function, and it has been shown that inhibition of
autophagy with 3-MA can block MLB expression in the
lung in type II alveolar Mv1Lu cells transfected with
Mgat5 (Hariri et al., 2000). Stimulation of autophagy by
serum starvation can result in an increased size of MLBs
in NP type C-mimicking drug U18666A-induced
cholesterol-rich lysosomal vacuoles (Lajoie et al., 2005).
All cell types found in the eye rely upon replenishment
or regeneration through removal of destroyed/unused
proteins and cell organelles. Autophagy has an essential
role in maintaining the physiological state and balance of
the eye (Petrovski et al., 2012). Autophagy is
responsible for the maturation of lens fiber cells,
removal of shed outer segments from photoreceptors in
the retinal pigment epithelium (RPE); moreover, it is
involved in mechanisms described in the pathogenesis of
dystrophies affecting the corneal endothelium (Frost et
al., 2014).
The TEM results demostrate that autophagy
inhibition reduces the number of MLBs and leads to
formation of dense vacuoles that are processed or
degraded through the MLB pathway. In accordance with
the previous findings, when cells were treated with RAP
or exposed to serum starvation, the rate of autophagy
increased in the 3D corneal stroma outgrowing cells,
resulting in greater number and slightly enlarged MLBs.
The TEM results were further supported by immuno-
fluorescent staining for the markers of autophagy (LC3
and p62), showing punctated appearance of the
autophagic vacuoles under RAP and starvation
treatment, while the decreased immunopositivity of the
autophagy markers indicates the presence of moderate
autophagic activity.
Defects in the autophagy clearance systems have
been known to cause pathogenic changes in certain
diseases; in type 2 granular corneal dystrophy (GCD2),
accumulation of mutant TGFβ-induced protein
(TGFβIp) causes hampered autophagic clearance and
ultimately vision impairment (Choi et al., 2012). It was
later reported that corneal fibroblasts from homozygous
GCD2 patients exhibit a significantly higher LC3-II and
p62 expression compared to wild type fibroblasts (Choi
and Kim, 2015). When wounded, quiescent corneal
stromal keratocytes become activated and undergo
transdifferentiation into myo/fibroblasts through
activation of the TGFβ signalling. Scar tissue formation
can lead to disturbed ECM formation, and eventually
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hazy cornea (Hassell and Birk, 2010).
Our long-term cultivated CSMSCs for over 3
months and without any passaging, have been hereby
considered as nearly as close a model for studying
corneal dystrophy as the in vivo conditions. The process
of producing and self-assembling the corneal stroma ex
vivo, with strong expression of collagen type I, and the
evidence for presence and inhibition of autophagy in this
3D structure, thus decreasing the formation of MBLs
(summarized in Fig. 5), can serve the role of slowing
down the progressive loss of stromal transparency in
SCD or any other condition involving MLBs and/or
autophagy degradation pathway involvement. 
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